ES8105930A1 - Procedimiento para la preparacion de vacunas de virus poli- valentes - Google Patents

Procedimiento para la preparacion de vacunas de virus poli- valentes

Info

Publication number
ES8105930A1
ES8105930A1 ES493433A ES493433A ES8105930A1 ES 8105930 A1 ES8105930 A1 ES 8105930A1 ES 493433 A ES493433 A ES 493433A ES 493433 A ES493433 A ES 493433A ES 8105930 A1 ES8105930 A1 ES 8105930A1
Authority
ES
Spain
Prior art keywords
polyvalent
virus
vaccines
cell system
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES493433A
Other languages
English (en)
Other versions
ES493433A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gist Brocades NV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Publication of ES8105930A1 publication Critical patent/ES8105930A1/es
Publication of ES493433A0 publication Critical patent/ES493433A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Abstract

METODO DE PREPARACION DE VACUNAS DE VIRUS POLIVALENTES. SE INFECTA UN SISTEMA UNICELULAR ADECUADO CON UNA CEPA DEL VIRUS DE LA RABIA Y SE PROPAGA EL VIRUS DURANTE 3 4 DIAS. SE INFECTA EL SISTEMA CELULAR CON AL MENOS UN VIRUS DISTEMPER CANINO Y SE PROPAGAN LOS VIRUS. TRANSCURRIDOS DE 1 A 4 DIAS SE RECOGE EL MEDIO CON LAS CELULAS Y SE PROCEDE A LA CONGELACION. SE DESCONGELA Y LOS RESTOS CELULARES SE SEPARAN POR CENTRIFUGADO O FILTRACION, MANTENIENDO EL LIQUIDO CON LOS VIRUS A UNA TEMPERATURA INFERIOR A -70 G. OPCIONALMENTE SE AÑADEN AL PRODUCTO FINAL ESTABILIZANTES Y AGENTES PRESERVANTES. SE USAN PARA LA INMUNIZACION DE ANIMALES DE SANGRE CALIENTE.
ES493433A 1979-07-17 1980-07-16 Procedimiento para la preparacion de vacunas de virus poli- valentes Granted ES493433A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7924916A GB2053679A (en) 1979-07-17 1979-07-17 Rabies/canine distemper vaccines

Publications (2)

Publication Number Publication Date
ES8105930A1 true ES8105930A1 (es) 1981-07-01
ES493433A0 ES493433A0 (es) 1981-07-01

Family

ID=10506559

Family Applications (1)

Application Number Title Priority Date Filing Date
ES493433A Granted ES493433A0 (es) 1979-07-17 1980-07-16 Procedimiento para la preparacion de vacunas de virus poli- valentes

Country Status (11)

Country Link
US (1) US4351827A (es)
EP (1) EP0023731A3 (es)
JP (1) JPS5622734A (es)
CA (1) CA1144860A (es)
DK (1) DK307080A (es)
ES (1) ES493433A0 (es)
GB (1) GB2053679A (es)
GR (1) GR69591B (es)
IL (1) IL60370A0 (es)
PT (1) PT71537A (es)
ZA (1) ZA803845B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358438A (en) * 1979-07-17 1982-11-09 Gist-Brocades N.V. Novel polyvalent virus vaccine against rabies and canine distemper
GB2053679A (en) * 1979-07-17 1981-02-11 Gist Brocades Nv Rabies/canine distemper vaccines
US4584194A (en) * 1980-07-30 1986-04-22 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4726946A (en) * 1980-07-30 1988-02-23 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4711778A (en) * 1980-07-30 1987-12-08 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4657761A (en) * 1985-06-05 1987-04-14 Pinto Cesar M Polyvalent non-specific immuno-stimulating vaccine and method
DE3640861A1 (de) 1986-11-29 1988-06-09 Beiersdorf Ag Aufreissstreifen
US5024836A (en) * 1987-05-04 1991-06-18 Merck & Co., Inc. Stable lyophilized live herpes virus vaccine
CN114470184A (zh) * 2021-12-30 2022-05-13 孙嘉玮 一种兽用破伤风、犬瘟热、狂犬病联合疫苗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE557508A (es) *
US2908614A (en) * 1954-08-10 1959-10-13 Glaxo Lab Ltd Use of dextran in freeze-drying process
US3155589A (en) * 1958-04-14 1964-11-03 Upjohn Co Parenteral extravascular injectable vaccines for simultaneous immunization of canidae against rabies, canine distemper, and infectious canine hepatitis
GB1015262A (en) * 1962-02-09 1965-12-31 Nat Res Dev Virus culture
GB1114143A (en) * 1963-12-06 1968-05-15 Nat Res Dev Cell lines and the cultivation of viruses therein
DE1924304C3 (de) * 1969-05-13 1980-07-17 Bayer Ag, 5090 Leverkusen Diäthylaminoäthyldextran (DEAE-D) als Adjuvans für Impfstoffe zur aktiven Immunisierung von Säugetieren
NL7015493A (es) * 1969-11-14 1971-05-18
GB2053679A (en) * 1979-07-17 1981-02-11 Gist Brocades Nv Rabies/canine distemper vaccines

Also Published As

Publication number Publication date
EP0023731A2 (en) 1981-02-11
PT71537A (en) 1980-08-01
DK307080A (da) 1981-01-18
GB2053679A (en) 1981-02-11
IL60370A0 (en) 1980-09-16
JPS5622734A (en) 1981-03-03
ZA803845B (en) 1981-06-24
US4351827A (en) 1982-09-28
ES493433A0 (es) 1981-07-01
GR69591B (es) 1982-07-05
CA1144860A (en) 1983-04-19
EP0023731A3 (en) 1981-11-11

Similar Documents

Publication Publication Date Title
ES8401128A1 (es) Procedimiento de obtencion de vacunas de bronquitis infecciosa para aves de corral.
PT98202A (pt) Processo para a preparacao de uma vacina contra a doenca de lyme, compreendendo uma quantidade dos principais antigenios contra b.burgdorferi
ES8105930A1 (es) Procedimiento para la preparacion de vacunas de virus poli- valentes
IL77694A (en) Canine parvovirus vaccines comprising viruses of the canine parvovirus strain 154 or viruses derived therefrom by additional cell culture passaging
AU554080B2 (en) Production of viral antisens
Enders General preface to studies on the cultivation of poliomyelitis viruses in tissue culture
NZ295070A (en) Attenuated viruses with additional DNA methylation sites in the viral genome for use thereof in vaccines
ES8200227A1 (es) Procedimiento de obtencion de vacunas de bronquitis in- fecciosa para aves de corral
EP0019218A3 (en) Influenza virus vaccines, process for preparing them, process for propagating influenza viruses and cell culture inoculated with influenza virus
ES466359A1 (es) Procedimiento para preparar vacunas vivas e inactivas del virus de la rabia.
DE3585578D1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
DE3888290D1 (de) Mutanten des infektiösen bovinen Rhinotracheitisvirus, Vakzine die sie enthalten, Verfahren zu ihrer Herstellung und ihrer Verwendung.
US3709782A (en) Heteroploid cell lines
Wahren et al. Monocyte and iscom enhancement of cell-mediated response to cytomegalovirus
YU242390A (sh) Matrica s celicami, vezanimi nanjo adherentno, kot tudi postopek za proizvodnjo virusa/virusantigena
JPS5781415A (en) Single strain vaccine for infectious disease by some strains of cilia bacteria
DK0592636T3 (da) Fremgangsmåde til fremstilling af en levedygtig cellekultur, der er inficeret med en med dissemineret sklerose forbundet vi
DE2966648D1 (en) Vaccine against diseases caused by reo viruses, combined vaccine with newcastle disease virus, process for preparing them and reo virus strain used for their preparation
Crainic et al. Neutralization epitope patterns of poliovirus strains isolated from paralytic cases
Wolff et al. Preparation of Cell-Free Feline Oncornavirus-Associated Cell Membrane Antigen
O'brien et al. Vaccinia virus: Kinetics of the hemagglutination-inhibition test and preparation of hemagglutinin
Hyllseth et al. Cross Neutralization of Maedi‐Visna Virus Strains
vd Ouweland et al. Characteristisc of a multicopy gene family predominantly consisting of processed pseudogeneses
Obinata et al. Induction of transdifferentation of epidermal-cells to mucois-secretin cells by eight hours treatment with retinol and its enhancement by 2-phosphoascorbate
JPH07561B2 (ja) 牛アデノウイルス７型ワクチン